Interleukin-2 available in two formats – powder or liquid. This growth factor reliably activates T lymphocytes for efficient cell expansion. Meets USP <1043> for cell therapy ancillary material as applicable to supplier. Gain peace of mind. Produced under a certified GMP license regularly qualified by licensing authorities.

白细胞介素-2 促进 T 和 B 淋巴细胞的生长、活性和维持。 IL-2 在许多细胞和基于细胞的基因疗法中至关重要。 可提供监管支持文件 (RSF)。 Xuri 生长因子按照相关 cGMP 准则生产、测试和 …

Xuri IL-2 is a human recombinant interleukin-2 for the promotion of activated human T lymphocyte expansion. Xuri IL-2 is provided as lyophilized powder to be reconstituted prior to use. The product is for single use only. Xuri IL-2 is produced by recombinant expression of the human sequence for interleukin-2 in Escherichia coli.

Xuri IL-2 生长因子，临床生产级配方，可装在西林瓶或注射器中，用于细胞治疗应用该生长因子可靠地激活 T 淋巴细胞，从而有效扩增细胞。 符合 USP &lt;1043&gt;适用于供应商的细胞治疗辅助材料要求。

我们对注射器包装的 Xuri™ IL-2 ( 三个批次）和冻干剂的 Xuri™IL-2 进行了性能对比。 通过测量支持细胞生长的能力、细胞活性、表型 ( CD3 / CD4 / CD8 ) 和激活水平 ( CD25 ) 比较两者性能。

earch applications. XuriTM IL-2, IL-15, and IL-21 growth factors are developed following the recommendations of USP <1043> “ancillary materials for cell, gene, and tissue-engineered products” and manufactured under relevant current good manufacturing proces.

2014年5月13日 · Xuri™ IL-2 is a dedicated cell therapy ancillary product for the ex vivo cultivation of T-lymphocytes. Xuri IL-2’s defined level of biological activity removes the need for revalidation of each lot and strongly improves reproducibility, thereby minimizing process development time and improving scale out capacity.

Xuri 细胞扩增系统 W25 为细胞治疗研究、工艺开发和生产领域的细胞生长提供了自动化、可靠的扩增环境，工作体积最大达到 25L。 Xuri 细胞扩增系统 W25 _系统_细胞治疗技术_思拓凡官网 | Cytiva

Xuri IL-2分别按照ISO 13408-2和ISO 13408-3执行标准进行灭菌和冻干。 如何从小瓶里尽可能地提取出所有的蛋白？ 所遵循的一般流程如下:

In this study, we evaluated the stability of Cytiva’s Xuri™ IL-2 growth factor as a function of time, temperature, medium, IL-2 lot, and initial concentration. ELISA data over 8 days showed excellent stability over time (half-life of > 8 days).